Granular 发表于 2025-3-30 08:42:59
Biomarkers in Breast Carcinomas,., and ., have enabled clinicians to detect underlying genetic alterations, develop novel therapeutic approaches, and predict therapy response in these patients. Nevertheless, in order to improve prognosis and survival of these patients, accurate application and correct evaluation of molecular altersacrum 发表于 2025-3-30 13:48:54
http://reply.papertrans.cn/19/1879/187808/187808_52.png半圆凿 发表于 2025-3-30 17:24:27
Diagnostic Approach According to Uncovered Metastatic Sites: Mediastinum-Thymus, Peritoneum, Centraemical panel including mesothelial markers such as calretinin and D2-40, a Müllerian marker such as PAX-8, ER, and epithelial markers such as Ber-EP4 and MOC-31 are useful. Additionally, homozygous deletion of BRCA1-associated protein 1(BAP-1) or p16 detected by FISH is specific for peritoneal mesotsemble 发表于 2025-3-30 23:36:28
http://reply.papertrans.cn/19/1879/187808/187808_54.pngkyphoplasty 发表于 2025-3-31 01:46:35
http://reply.papertrans.cn/19/1879/187808/187808_55.png合同 发表于 2025-3-31 07:42:57
http://reply.papertrans.cn/19/1879/187808/187808_56.pngCredence 发表于 2025-3-31 10:09:56
http://reply.papertrans.cn/19/1879/187808/187808_57.pngintegral 发表于 2025-3-31 14:19:26
http://reply.papertrans.cn/19/1879/187808/187808_58.png